Clinical Trials Directory

Trials / Completed

CompletedNCT01745172

Carotid Body Removal for the Treatment of Resistant Hypertension

Carotid Body Removal for the Treatment of Chronic Diseases Characterized by Excessive Central Sympathetic Activity Including Resistant Hypertension: a Pilot Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Noblewell · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a pilot study to assess the effectiveness, safety and feasibility of carotid body removal in patients with high blood pressure (hypertension) resistant to medical treatment. Patients with high blood pressure are at significant risk of medical complications including stroke and heart disease. The principle research question is whether removal of the carotid body will lead to an improvement in the blood pressure of this patient group.

Conditions

Interventions

TypeNameDescription
PROCEDURECarotid body excisionThis surgery does not involve any study drug or investigational device. The carotid body will be removed by the so called 'lateral approach' or a combined 'lateral and medial approach'. In all cases the target area was defined as the tissue in between the ECA and ICA, up to 5-6mm above the bifurcation point of the common carotid artery into the ECA and ICA. In a lateral approach the carotid bifurcation is not turned. A combined approach includes usually dissection of the superior thyroid vessel and turning of the carotid bifurcation.

Timeline

Start date
2013-01-01
Primary completion
2016-05-01
Completion
2016-06-01
First posted
2012-12-10
Last updated
2016-10-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01745172. Inclusion in this directory is not an endorsement.